United States Metabolomics Market Report 2017

August 2017 | 113 pages | ID: U95D22261CDEN
QYResearch

Abstracts

In this report, the United States Metabolomics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Metabolomics in these regions, from 2012 to 2022 (forecast).

United States Metabolomics market competition by top manufacturers/players, with Metabolomics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Shimadzu Corporation
• Bio-Rad Laboratories
• Bruker Corporation
• Danaher Corporation
• Human Metabolome Technologies
• LECO Corporation
• Agilent Technologies
• Biocrates Life Sciences AG
• Thermo Fisher Scientific
• Waters Corporation
• Metabolon

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Metabolomic Instruments
• Metabolomic Bioinformatics Tools And Services

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Metabolomics for each application, including

• Cardiovascular Disorders
• Inborn Errors Of Metabolism
• Cancer
• Neurological Disorders
• Others

Contents

United States Metabolomics Market Report 2017

1 METABOLOMICS OVERVIEW

1.1 Product Overview and Scope of Metabolomics
1.2 Classification of Metabolomics by Product Category
  1.2.1 United States Metabolomics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Metabolomics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Metabolomic Instruments
  1.2.4 Metabolomic Bioinformatics Tools And Services
1.3 United States Metabolomics Market by Application/End Users
  1.3.1 United States Metabolomics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cardiovascular Disorders
  1.3.3 Inborn Errors Of Metabolism
  1.3.4 Cancer
  1.3.5 Neurological Disorders
  1.3.6 Others
1.4 United States Metabolomics Market by Region
  1.4.1 United States Metabolomics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Metabolomics Status and Prospect (2012-2022)
  1.4.3 Southwest Metabolomics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Metabolomics Status and Prospect (2012-2022)
  1.4.5 New England Metabolomics Status and Prospect (2012-2022)
  1.4.6 The South Metabolomics Status and Prospect (2012-2022)
  1.4.7 The Midwest Metabolomics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Metabolomics (2012-2022)
  1.5.1 United States Metabolomics Sales and Growth Rate (2012-2022)
  1.5.2 United States Metabolomics Revenue and Growth Rate (2012-2022)

2 UNITED STATES METABOLOMICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Metabolomics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Metabolomics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Metabolomics Average Price by Players/Suppliers (2012-2017)
2.4 United States Metabolomics Market Competitive Situation and Trends
  2.4.1 United States Metabolomics Market Concentration Rate
  2.4.2 United States Metabolomics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Metabolomics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES METABOLOMICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Metabolomics Sales and Market Share by Region (2012-2017)
3.2 United States Metabolomics Revenue and Market Share by Region (2012-2017)
3.3 United States Metabolomics Price by Region (2012-2017)

4 UNITED STATES METABOLOMICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Metabolomics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Metabolomics Revenue and Market Share by Type (2012-2017)
4.3 United States Metabolomics Price by Type (2012-2017)
4.4 United States Metabolomics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES METABOLOMICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Metabolomics Sales and Market Share by Application (2012-2017)
5.2 United States Metabolomics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES METABOLOMICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Shimadzu Corporation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Metabolomics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shimadzu Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bio-Rad Laboratories
  6.2.2 Metabolomics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bio-Rad Laboratories Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bruker Corporation
  6.3.2 Metabolomics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bruker Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Danaher Corporation
  6.4.2 Metabolomics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Danaher Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Human Metabolome Technologies
  6.5.2 Metabolomics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Human Metabolome Technologies Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 LECO Corporation
  6.6.2 Metabolomics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 LECO Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Agilent Technologies
  6.7.2 Metabolomics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Agilent Technologies Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Biocrates Life Sciences AG
  6.8.2 Metabolomics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Biocrates Life Sciences AG Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Thermo Fisher Scientific
  6.9.2 Metabolomics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Thermo Fisher Scientific Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Waters Corporation
  6.10.2 Metabolomics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Waters Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Metabolon

7 METABOLOMICS MANUFACTURING COST ANALYSIS

7.1 Metabolomics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Metabolomics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Metabolomics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Metabolomics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES METABOLOMICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Metabolomics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Metabolomics Sales Volume Forecast by Type (2017-2022)
11.3 United States Metabolomics Sales Volume Forecast by Application (2017-2022)
11.4 United States Metabolomics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Metabolomics
Figure United States Metabolomics Market Size (K Units) by Type (2012-2022)
Figure United States Metabolomics Sales Volume Market Share by Type (Product Category) in 2016
Figure Metabolomic Instruments Product Picture
Figure Metabolomic Bioinformatics Tools And Services Product Picture
Figure United States Metabolomics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Metabolomics by Application in 2016
Figure Cardiovascular Disorders Examples
Figure Inborn Errors Of Metabolism Examples
Figure Cancer Examples
Figure Neurological Disorders Examples
Figure Others Examples
Figure United States Metabolomics Market Size (Million USD) by Region (2012-2022)
Figure The West Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Metabolomics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Metabolomics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Metabolomics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Metabolomics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Metabolomics Sales Share by Players/Suppliers
Figure 2017 United States Metabolomics Sales Share by Players/Suppliers
Figure United States Metabolomics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Metabolomics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Metabolomics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Metabolomics Revenue Share by Players/Suppliers
Figure 2017 United States Metabolomics Revenue Share by Players/Suppliers
Table United States Market Metabolomics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Metabolomics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Metabolomics Market Share of Top 3 Players/Suppliers
Figure United States Metabolomics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Metabolomics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Metabolomics Product Category
Table United States Metabolomics Sales (K Units) by Region (2012-2017)
Table United States Metabolomics Sales Share by Region (2012-2017)
Figure United States Metabolomics Sales Share by Region (2012-2017)
Figure United States Metabolomics Sales Market Share by Region in 2016
Table United States Metabolomics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Metabolomics Revenue Share by Region (2012-2017)
Figure United States Metabolomics Revenue Market Share by Region (2012-2017)
Figure United States Metabolomics Revenue Market Share by Region in 2016
Table United States Metabolomics Price (USD/Unit) by Region (2012-2017)
Table United States Metabolomics Sales (K Units) by Type (2012-2017)
Table United States Metabolomics Sales Share by Type (2012-2017)
Figure United States Metabolomics Sales Share by Type (2012-2017)
Figure United States Metabolomics Sales Market Share by Type in 2016
Table United States Metabolomics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Metabolomics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Metabolomics by Type (2012-2017)
Figure Revenue Market Share of Metabolomics by Type in 2016
Table United States Metabolomics Price (USD/Unit) by Types (2012-2017)
Figure United States Metabolomics Sales Growth Rate by Type (2012-2017)
Table United States Metabolomics Sales (K Units) by Application (2012-2017)
Table United States Metabolomics Sales Market Share by Application (2012-2017)
Figure United States Metabolomics Sales Market Share by Application (2012-2017)
Figure United States Metabolomics Sales Market Share by Application in 2016
Table United States Metabolomics Sales Growth Rate by Application (2012-2017)
Figure United States Metabolomics Sales Growth Rate by Application (2012-2017)
Table Shimadzu Corporation Basic Information List
Table Shimadzu Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shimadzu Corporation Metabolomics Sales Growth Rate (2012-2017)
Figure Shimadzu Corporation Metabolomics Sales Market Share in United States (2012-2017)
Figure Shimadzu Corporation Metabolomics Revenue Market Share in United States (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Metabolomics Sales Growth Rate (2012-2017)
Figure Bio-Rad Laboratories Metabolomics Sales Market Share in United States (2012-2017)
Figure Bio-Rad Laboratories Metabolomics Revenue Market Share in United States (2012-2017)
Table Bruker Corporation Basic Information List
Table Bruker Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bruker Corporation Metabolomics Sales Growth Rate (2012-2017)
Figure Bruker Corporation Metabolomics Sales Market Share in United States (2012-2017)
Figure Bruker Corporation Metabolomics Revenue Market Share in United States (2012-2017)
Table Danaher Corporation Basic Information List
Table Danaher Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Danaher Corporation Metabolomics Sales Growth Rate (2012-2017)
Figure Danaher Corporation Metabolomics Sales Market Share in United States (2012-2017)
Figure Danaher Corporation Metabolomics Revenue Market Share in United States (2012-2017)
Table Human Metabolome Technologies Basic Information List
Table Human Metabolome Technologies Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Human Metabolome Technologies Metabolomics Sales Growth Rate (2012-2017)
Figure Human Metabolome Technologies Metabolomics Sales Market Share in United States (2012-2017)
Figure Human Metabolome Technologies Metabolomics Revenue Market Share in United States (2012-2017)
Table LECO Corporation Basic Information List
Table LECO Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LECO Corporation Metabolomics Sales Growth Rate (2012-2017)
Figure LECO Corporation Metabolomics Sales Market Share in United States (2012-2017)
Figure LECO Corporation Metabolomics Revenue Market Share in United States (2012-2017)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Agilent Technologies Metabolomics Sales Growth Rate (2012-2017)
Figure Agilent Technologies Metabolomics Sales Market Share in United States (2012-2017)
Figure Agilent Technologies Metabolomics Revenue Market Share in United States (2012-2017)
Table Biocrates Life Sciences AG Basic Information List
Table Biocrates Life Sciences AG Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocrates Life Sciences AG Metabolomics Sales Growth Rate (2012-2017)
Figure Biocrates Life Sciences AG Metabolomics Sales Market Share in United States (2012-2017)
Figure Biocrates Life Sciences AG Metabolomics Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Metabolomics Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Metabolomics Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Metabolomics Revenue Market Share in United States (2012-2017)
Table Waters Corporation Basic Information List
Table Waters Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Waters Corporation Metabolomics Sales Growth Rate (2012-2017)
Figure Waters Corporation Metabolomics Sales Market Share in United States (2012-2017)
Figure Waters Corporation Metabolomics Revenue Market Share in United States (2012-2017)
Table Metabolon Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metabolomics
Figure Manufacturing Process Analysis of Metabolomics
Figure Metabolomics Industrial Chain Analysis
Table Raw Materials Sources of Metabolomics Major Players/Suppliers in 2016
Table Major Buyers of Metabolomics
Table Distributors/Traders List
Figure United States Metabolomics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Metabolomics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Metabolomics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Metabolomics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Metabolomics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Metabolomics Sales Volume (K Units) Forecast by Type in 2022
Table United States Metabolomics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Metabolomics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Metabolomics Sales Volume (K Units) Forecast by Application in 2022
Table United States Metabolomics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Metabolomics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Metabolomics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Metabolomics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources